《强生Johnson &ampamp Johnson（JNJ）2024年第四季度及全年业绩报告「NYSE」（英文版）（22页）.pdf》由会员分享，可在线阅读，更多相关《强生Johnson &ampamp Johnson（JNJ）2024年第四季度及全年业绩报告「NYSE」（英文版）（22页）.pdf（22页珍藏版）》请在三个皮匠报告上搜索。

1、For immediate release 2.0%3.0%/2.5%$90.9B$91.7B/$91.3B 2.5%3.5%/3.0%$89.2B$90.0B/$89.6B 0.5%1.5%/1.0%$10.75$10.95/$10.85 7.7%9.7%/8.7%$10.50$10.70/$10.60 5.2%7.2%/6.2%Johnson&Johnson and SubsidiariesSupplementary Sales Data(Unaudited;Dollars in Millions)Percent Change20242023TotalOperationsCurrency2

2、0242023TotalOperationsCurrencySales to customers bysegment of businessInnovative Medicine(1)U.S.8,977$8,079 11.1%11.1 -33,970$31,169 9.0%9.0 -International5,355 5,643 (5.1)(1.0)(4.1)22,994 23,590 (2.5)1.3 (3.8)14,332 13,722 4.4 6.1 (1.7)56,964 54,759 4.0 5.7 (1.7)Innovative Medicine excluding COVID-

3、19 Vaccine(1)U.S.8,977 8,079 11.1 11.1 -33,970 31,169 9.0 9.0 -International5,355 5,599 (4.4)(0.3)(4.1)22,796 22,473 1.4 5.5 (4.1)14,332 13,678 4.8 6.5 (1.7)56,766 53,642 5.8 7.5 (1.7)MedTech U.S.4,227 3,930 7.6 7.6 -16,332 15,275 6.9 6.9 -International3,961 3,743 5.8 7.6 (1.8)15,525 15,125 2.6 5.4

4、(2.8)8,188 7,673 6.7 7.6 (0.9)31,857 30,400 4.8 6.2 (1.4)U.S.13,204 12,009 10.0 10.0 -50,302 46,444 8.3 8.3 -International9,316 9,386 (0.7)2.5 (3.2)38,519 38,715 (0.5)2.9 (3.4)Worldwide22,520 21,395 5.3 6.7 (1.4)88,821 85,159 4.3 5.9 (1.6)U.S.13,204 12,009 10.0 10.0 -50,302 46,444 8.3 8.3 -Internati

5、onal9,316 9,342 (0.3)2.9 (3.2)38,321 37,598 1.9 5.5 (3.6)Worldwide excluding COVID-19 Vaccine(1)22,520$21,351 5.5%6.9 (1.4)88,623$84,042 5.5%7.0 (1.5)Note:Percentages have been calculated using actual,non-rounded figures and,therefore,may not recalculate precisely.(1)Refer to supplemental sales info

6、rmation schedulesFOURTH QUARTERTWELVE MONTHS Percent ChangeJohnson&Johnson and SubsidiariesSupplementary Sales Data(Unaudited;Dollars in Millions)Percent Change20242023TotalOperationsCurrency20242023TotalOperationsCurrencySales to customers bygeographic areaU.S.13,204$12,009 10.0%10.0 -50,302$46,444